The Cooper Companies, Inc. (COO)
USD 77.69
(3.08%)
USD 77.69
(3.08%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.1 Billion USD | -4.86% |
| 2022 | 4.31 Billion USD | 62.06% |
| 2021 | 2.66 Billion USD | -8.53% |
| 2020 | 2.91 Billion USD | 10.08% |
| 2019 | 2.64 Billion USD | -5.67% |
| 2018 | 2.8 Billion USD | 66.68% |
| 2017 | 1.68 Billion USD | -5.24% |
| 2016 | 1.77 Billion USD | -0.61% |
| 2015 | 1.78 Billion USD | -4.45% |
| 2014 | 1.86 Billion USD | 161.98% |
| 2013 | 713.76 Million USD | -1.99% |
| 2012 | 728.22 Million USD | 6.0% |
| 2011 | 687.03 Million USD | -19.95% |
| 2010 | 858.24 Million USD | -15.16% |
| 2009 | 1.01 Billion USD | -13.58% |
| 2008 | 1.17 Billion USD | 2.98% |
| 2007 | 1.13 Billion USD | 16.69% |
| 2006 | 974.09 Million USD | 7.44% |
| 2005 | 906.6 Million USD | 239.04% |
| 2004 | 267.4 Million USD | -5.68% |
| 2003 | 283.51 Million USD | 9.18% |
| 2002 | 259.67 Million USD | 84.74% |
| 2001 | 140.56 Million USD | 13.24% |
| 2000 | 124.12 Million USD | 1.91% |
| 1999 | 121.8 Million USD | -19.18% |
| 1998 | 150.7 Million USD | 136.21% |
| 1997 | 63.8 Million USD | -27.17% |
| 1996 | 87.6 Million USD | -6.51% |
| 1995 | 93.7 Million USD | -5.16% |
| 1994 | 98.8 Million USD | -9.36% |
| 1993 | 109 Million USD | -14.58% |
| 1992 | 127.6 Million USD | 10.09% |
| 1991 | 115.9 Million USD | -12.13% |
| 1990 | 131.9 Million USD | -29.2% |
| 1989 | 186.3 Million USD | -82.91% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 4.18 Billion USD | -1.43% |
| 2024 Q1 | 4.33 Billion USD | 5.58% |
| 2024 Q2 | 4.24 Billion USD | -2.16% |
| 2023 FY | 4.1 Billion USD | -4.86% |
| 2023 Q3 | 4.16 Billion USD | 0.18% |
| 2023 Q2 | 4.16 Billion USD | -1.51% |
| 2023 Q1 | 4.22 Billion USD | -2.14% |
| 2023 Q4 | 4.1 Billion USD | -1.46% |
| 2022 Q2 | 4.76 Billion USD | 0.59% |
| 2022 Q4 | 4.31 Billion USD | -3.39% |
| 2022 FY | 4.31 Billion USD | 62.06% |
| 2022 Q1 | 4.73 Billion USD | 77.78% |
| 2022 Q3 | 4.46 Billion USD | -6.2% |
| 2021 Q3 | 2.82 Billion USD | -0.9% |
| 2021 Q4 | 2.66 Billion USD | -5.7% |
| 2021 Q2 | 2.85 Billion USD | -2.76% |
| 2021 Q1 | 2.93 Billion USD | 0.66% |
| 2021 FY | 2.66 Billion USD | -8.53% |
| 2020 FY | 2.91 Billion USD | 10.08% |
| 2020 Q4 | 2.91 Billion USD | -2.52% |
| 2020 Q3 | 2.98 Billion USD | 3.66% |
| 2020 Q1 | 2.81 Billion USD | 6.49% |
| 2020 Q2 | 2.88 Billion USD | 2.3% |
| 2019 Q2 | 2.66 Billion USD | -7.38% |
| 2019 Q3 | 2.55 Billion USD | -3.9% |
| 2019 FY | 2.64 Billion USD | -5.67% |
| 2019 Q4 | 2.64 Billion USD | 3.47% |
| 2019 Q1 | 2.87 Billion USD | 2.43% |
| 2018 FY | 2.8 Billion USD | 66.68% |
| 2018 Q2 | 3.22 Billion USD | 3.67% |
| 2018 Q3 | 3.03 Billion USD | -6.08% |
| 2018 Q4 | 2.8 Billion USD | -7.43% |
| 2018 Q1 | 3.11 Billion USD | 84.93% |
| 2017 Q1 | 1.83 Billion USD | 3.46% |
| 2017 Q3 | 1.68 Billion USD | -6.66% |
| 2017 Q4 | 1.68 Billion USD | -0.39% |
| 2017 FY | 1.68 Billion USD | -5.24% |
| 2017 Q2 | 1.81 Billion USD | -1.49% |
| 2016 FY | 1.77 Billion USD | -0.61% |
| 2016 Q4 | 1.77 Billion USD | -4.28% |
| 2016 Q3 | 1.85 Billion USD | -0.06% |
| 2016 Q2 | 1.85 Billion USD | 3.42% |
| 2016 Q1 | 1.79 Billion USD | 0.47% |
| 2015 Q1 | 1.81 Billion USD | -2.73% |
| 2015 Q4 | 1.78 Billion USD | 3.35% |
| 2015 Q3 | 1.72 Billion USD | -2.71% |
| 2015 Q2 | 1.77 Billion USD | -2.3% |
| 2015 FY | 1.78 Billion USD | -4.45% |
| 2014 Q3 | 691.09 Million USD | 4.73% |
| 2014 Q2 | 659.9 Million USD | -0.14% |
| 2014 Q1 | 660.84 Million USD | -7.41% |
| 2014 Q4 | 1.86 Billion USD | 170.57% |
| 2014 FY | 1.86 Billion USD | 161.98% |
| 2013 Q2 | 630.23 Million USD | -12.47% |
| 2013 Q4 | 713.76 Million USD | 25.38% |
| 2013 Q3 | 569.26 Million USD | -9.67% |
| 2013 FY | 713.76 Million USD | -1.99% |
| 2013 Q1 | 719.99 Million USD | -1.13% |
| 2012 Q2 | 590.6 Million USD | -10.77% |
| 2012 Q1 | 661.91 Million USD | -3.66% |
| 2012 Q4 | 728.22 Million USD | -7.5% |
| 2012 FY | 728.22 Million USD | 6.0% |
| 2012 Q3 | 787.27 Million USD | 33.3% |
| 2011 Q3 | 727.65 Million USD | -10.7% |
| 2011 FY | 687.03 Million USD | -19.95% |
| 2011 Q4 | 687.03 Million USD | -5.58% |
| 2011 Q1 | 849.63 Million USD | -1.0% |
| 2011 Q2 | 814.86 Million USD | -4.09% |
| 2010 Q1 | 969.34 Million USD | -4.17% |
| 2010 Q3 | 908.92 Million USD | -5.96% |
| 2010 Q4 | 858.24 Million USD | -5.58% |
| 2010 Q2 | 966.49 Million USD | -0.29% |
| 2010 FY | 858.24 Million USD | -15.16% |
| 2009 Q1 | 1.17 Billion USD | 0.12% |
| 2009 Q2 | 1.11 Billion USD | -4.62% |
| 2009 FY | 1.01 Billion USD | -13.58% |
| 2009 Q4 | 1.01 Billion USD | -5.2% |
| 2009 Q3 | 1.06 Billion USD | -4.54% |
| 2008 Q2 | 1.19 Billion USD | 2.1% |
| 2008 FY | 1.17 Billion USD | 2.98% |
| 2008 Q1 | 1.17 Billion USD | 3.06% |
| 2008 Q4 | 1.17 Billion USD | -0.71% |
| 2008 Q3 | 1.17 Billion USD | -1.42% |
| 2007 Q1 | 1.06 Billion USD | 9.47% |
| 2007 FY | 1.13 Billion USD | 16.69% |
| 2007 Q4 | 1.13 Billion USD | 2.8% |
| 2007 Q3 | 1.1 Billion USD | 1.25% |
| 2007 Q2 | 1.09 Billion USD | 2.41% |
| 2006 Q1 | 967.59 Million USD | 6.73% |
| 2006 FY | 974.09 Million USD | 7.44% |
| 2006 Q2 | 960.49 Million USD | -0.73% |
| 2006 Q3 | 971.81 Million USD | 1.18% |
| 2006 Q4 | 974.09 Million USD | 0.23% |
| 2005 Q2 | 922.2 Million USD | -1.99% |
| 2005 FY | 906.6 Million USD | 239.04% |
| 2005 Q3 | 920.64 Million USD | -0.17% |
| 2005 Q4 | 906.6 Million USD | -1.52% |
| 2005 Q1 | 940.97 Million USD | 251.9% |
| 2004 Q4 | 267.4 Million USD | 1.34% |
| 2004 FY | 267.4 Million USD | -5.68% |
| 2004 Q3 | 263.87 Million USD | -1.66% |
| 2004 Q2 | 268.34 Million USD | 0.69% |
| 2004 Q1 | 266.5 Million USD | -6.0% |
| 2003 Q4 | 283.51 Million USD | 1.3% |
| 2003 Q2 | 247.02 Million USD | -6.44% |
| 2003 Q3 | 279.88 Million USD | 13.3% |
| 2003 FY | 283.51 Million USD | 9.18% |
| 2003 Q1 | 264.03 Million USD | 1.68% |
| 2002 Q1 | 127.25 Million USD | -9.47% |
| 2002 FY | 259.67 Million USD | 84.74% |
| 2002 Q4 | 259.67 Million USD | 0.74% |
| 2002 Q3 | 257.77 Million USD | 0.95% |
| 2002 Q2 | 255.33 Million USD | 100.65% |
| 2001 Q2 | 109.02 Million USD | -5.75% |
| 2001 Q4 | 140.56 Million USD | 12.14% |
| 2001 Q3 | 125.35 Million USD | 14.98% |
| 2001 Q1 | 115.67 Million USD | -6.81% |
| 2001 FY | 140.56 Million USD | 13.24% |
| 2000 FY | 124.12 Million USD | 1.91% |
| 2000 Q4 | 124.12 Million USD | 10.49% |
| 2000 Q1 | 121.6 Million USD | -0.16% |
| 2000 Q2 | 119.06 Million USD | -2.08% |
| 2000 Q3 | 112.34 Million USD | -5.65% |
| 1999 Q3 | 125.8 Million USD | -0.32% |
| 1999 Q2 | 126.2 Million USD | -11.31% |
| 1999 FY | 121.8 Million USD | -19.18% |
| 1999 Q4 | 121.8 Million USD | -3.18% |
| 1999 Q1 | 142.3 Million USD | -5.57% |
| 1998 Q1 | 132.6 Million USD | 107.84% |
| 1998 FY | 150.7 Million USD | 136.21% |
| 1998 Q4 | 150.7 Million USD | 4.65% |
| 1998 Q3 | 144 Million USD | 3.37% |
| 1998 Q2 | 139.3 Million USD | 5.05% |
| 1997 Q3 | 78 Million USD | -14.47% |
| 1997 Q4 | 63.8 Million USD | -18.21% |
| 1997 Q2 | 91.2 Million USD | 8.44% |
| 1997 Q1 | 84.1 Million USD | -4.0% |
| 1997 FY | 63.8 Million USD | -27.17% |
| 1996 Q4 | 87.6 Million USD | -1.02% |
| 1996 Q3 | 88.5 Million USD | -3.49% |
| 1996 FY | 87.6 Million USD | -6.51% |
| 1996 Q1 | 86.3 Million USD | -7.9% |
| 1996 Q2 | 91.7 Million USD | 6.26% |
| 1995 Q3 | 92.6 Million USD | 1.31% |
| 1995 Q4 | 93.7 Million USD | 1.19% |
| 1995 Q1 | 91.8 Million USD | -7.09% |
| 1995 FY | 93.7 Million USD | -5.16% |
| 1995 Q2 | 91.4 Million USD | -0.44% |
| 1994 Q3 | 101.9 Million USD | -2.58% |
| 1994 Q2 | 104.6 Million USD | 1.36% |
| 1994 Q4 | 98.8 Million USD | -3.04% |
| 1994 Q1 | 103.2 Million USD | -5.32% |
| 1994 FY | 98.8 Million USD | -9.36% |
| 1993 Q4 | 109 Million USD | -6.6% |
| 1993 Q2 | 120.2 Million USD | 10.58% |
| 1993 FY | 109 Million USD | -14.58% |
| 1993 Q3 | 116.7 Million USD | -2.91% |
| 1993 Q1 | 108.7 Million USD | -14.81% |
| 1992 Q2 | 101.5 Million USD | -16.67% |
| 1992 FY | 127.6 Million USD | 10.09% |
| 1992 Q4 | 127.6 Million USD | -2.22% |
| 1992 Q1 | 121.8 Million USD | 5.09% |
| 1992 Q3 | 130.5 Million USD | 28.57% |
| 1991 Q4 | 115.9 Million USD | 6.43% |
| 1991 Q3 | 108.9 Million USD | -11.54% |
| 1991 Q2 | 123.1 Million USD | -5.31% |
| 1991 Q1 | 130 Million USD | -1.44% |
| 1991 FY | 115.9 Million USD | -12.13% |
| 1990 FY | 131.9 Million USD | -29.2% |
| 1990 Q4 | 131.9 Million USD | 0.0% |
| 1989 FY | 186.3 Million USD | -82.91% |
| 1989 Q4 | 186.3 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | -3144.812% |
| AngioDynamics, Inc. | 112.08 Million USD | -3564.986% |
| AtriCure, Inc. | 147.76 Million USD | -2680.041% |
| Avinger, Inc. | 19.97 Million USD | -20468.296% |
| Azenta, Inc. | 351.22 Million USD | -1069.609% |
| BioLife Solutions, Inc. | 75.05 Million USD | -5373.478% |
| Daxor Corporation | 858.75 Thousand USD | -478253.622% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -25083.301% |
| Femasys Inc. | 9.4 Million USD | -43586.025% |
| GlucoTrack, Inc. | 1.7 Million USD | -240409.368% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -6289.442% |
| Hologic, Inc. | 4.02 Billion USD | -2.034% |
| ICU Medical, Inc. | 2.25 Billion USD | -82.166% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -100.954% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -50569.769% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -8304.395% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -622369.452% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -622369.452% |
| Masimo Corporation | 1.67 Billion USD | -144.999% |
| Microbot Medical Inc. | 3.82 Million USD | -107268.008% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -16280.852% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | -265.718% |
| Nephros, Inc. | 3.5 Million USD | -117168.056% |
| NovoCure Limited | 783.63 Million USD | -424.212% |
| NEXGEL, Inc. | 4.78 Million USD | -85677.824% |
| NEXGEL, Inc. | 4.78 Million USD | -85677.824% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | -4651.159% |
| OraSure Technologies, Inc. | 52.17 Million USD | -7773.462% |
| Pro-Dex, Inc. | 23.34 Million USD | -17497.995% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -24881.15% |
| Predictive Oncology Inc. | 6.14 Million USD | -66744.369% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -59915.025% |
| QuidelOrtho Corporation | 3.55 Billion USD | -15.481% |
| Repligen Corporation | 853.2 Million USD | -381.465% |
| Sanara MedTech Inc. | 29.28 Million USD | -13928.213% |
| STAAR Surgical Company | 102.73 Million USD | -3898.423% |
| Sharps Technology, Inc. | 3.85 Million USD | -106460.809% |
| Utah Medical Products, Inc. | 7.14 Million USD | -57393.352% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | -0.783% |
| Jin Medical International Ltd. | 8.92 Million USD | -45930.269% |